Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-26T15:44:08.521Z Has data issue: false hasContentIssue false

Iatrogenic reflux oesophagitis

Published online by Cambridge University Press:  29 June 2007

H. W. H. Shepperd
Affiliation:
Royal Victoria Hospital, Grosvenor Rd., Belfast BT12 6BA.

Summary

A report on two patients with severe reflux oesophagitis caused by Emepromium Bromide (‘CETIRPIN’) prescribed for the treatment of urinary symptoms.

Emepronium Bromide is a quaternary ammonium anticholinergic drug, which blocks the peripheral cholinergic nerves and ganglionic transmission. In man it increase bladder capacity, delays the first desire to void and decreases voiding pressure.

In the last eighteen months two patients have been referred with severe pain on swallowing. The pain was localized behind the sternum and reached down to the epigastrium. On both occasions the symptoms came on rapidly a few days after the treatment was begun. Both patients were on a standard dose of 200 mgs. three times daily. The first patient had had some minor reflux with her last pregnancy thirteen years previously, but otherwise no symptoms suggestive of reflux. The second patient had never has any symptoms suggestive of oesophageal reflux. In both patients a major feature was the severity of their pain.

Type
Clinical records
Copyright
Copyright © JLO (1984) Limited 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCE

Strouthidis, T. M., Mankikar, G. D. and Irvine, R. E. (1972) Lancet, 1, 72.CrossRefGoogle Scholar